Search Results - "Arnould, R."

Refine Results
  1. 1

    Mid-infrared prediction of lactoferrin content in bovine milk: potential indicator of mastitis by Soyeurt, H., Bastin, C., Colinet, F. G., Arnould, V. M.-R., Berry, D. P., Wall, E., Dehareng, F., Nguyen, H. N., Dardenne, P., Schefers, J., Vandenplas, J., Weigel, K., Coffey, M., Théron, L., Detilleux, J., Reding, E., Gengler, N., McParland, S.

    Published in Animal (Cambridge, England) (01-11-2012)
    “…Lactoferrin (LTF) is a milk glycoprotein favorably associated with the immune system of dairy cows. Somatic cell count is often used as an indicator of…”
    Get full text
    Journal Article Web Resource
  2. 2

    Genetic variability of lactoferrin content estimated by mid-infrared spectrometry in bovine milk by Soyeurt, H, Colinet, F G, Arnould, V M-R, Dardenne, P, Bertozzi, C, Renaville, R, Portetelle, D, Gengler, N

    Published in Journal of dairy science (01-09-2007)
    “…The effects of lactoferrin (LF) on the immune system have already been shown by many studies. Unfortunately, the current methods used to measure LF levels in…”
    Get more information
    Journal Article
  3. 3

    Genetic analysis of lactoferrin content in bovine milk by Arnould, V M-R, Soyeurt, H, Gengler, N, Colinet, F G, Georges, M V, Bertozzi, C, Portetelle, D, Renaville, R

    Published in Journal of dairy science (01-05-2009)
    “…Bovine lactoferrin (LF) is mainly present in milk and shows important physiological and biological functions. The aim of this study was to estimate the…”
    Get more information
    Journal Article
  4. 4

    Predictions of Daily Milk and Fat Yields, Major Groups of Fatty Acids, and C18:1 cis-9 from Single Milking Data without a Milking Interval by Arnould, Valérie M R, Reding, Romain, Bormann, Jeanne, Gengler, Nicolas, Soyeurt, Hélène

    Published in Animals (Basel) (31-07-2015)
    “…Reducing the frequency of milk recording would help reduce the costs of official milk recording. However, this approach could also negatively affect the…”
    Get full text
    Journal Article
  5. 5

    Review: milk composition as management tool of sustainability by Arnould, Valerie M-R, Reding, Romain, Bormann, Jeanne, Gengler, Nicolas, Soyeurt, Helene

    “…The main objective of tins paper is the use of milk composition data as a management tool. Milk composition, and in particular, milk fat content and fatty acid…”
    Get full text
    Journal Article
  6. 6

    Short communication: Genetic variation of saturated fatty acids in Holsteins in the Walloon region of Belgium by Arnould, V M-R, Hammami, H, Soyeurt, H, Gengler, N

    Published in Journal of dairy science (01-09-2010)
    “…Random regression test-day models using Legendre polynomials are commonly used for the estimation of genetic parameters and genetic evaluation for test-day…”
    Get more information
    Journal Article
  7. 7

    GPS monitoring of vertical ground motion in northern Ardenne–Eifel: five campaigns (1999–2003) of the HARD project by Demoulin, A., Campbell, J., Wulf, A. De, Muls, A., Arnould, R., Görres, B., Fischer, D., Kötter, T., Brondeel, M., Damme, D. Van, Jacqmotte, J. M.

    “…We present the HARD project of GPS monitoring of vertical ground motion in NE Ardenne and Eifel (western Europe). Its main purposes are to get a better insight…”
    Get full text
    Journal Article
  8. 8

    Hospital Mergers And Savings For Consumers: Exploring New Evidence by Spang, Heather Radach, Bazzoli, Gloria J, Arnould, Richard J

    Published in Health Affairs (01-07-2001)
    “…This study analyzes changes in costs and prices from 1989 to 1997 for 1,767 short-term hospitals, including 204 hospitals involved in mergers; 653 hospitals…”
    Get full text
    Journal Article
  9. 9

    Federal antitrust merger enforcement standards: a good fit for the hospital industry? by Bazzoli, G J, Marx, Jr, D, Arnould, R J, Manheim, L M

    “…We examine the implications of the 1992 Horizontal Merger Guidelines for the hospital industry and subsequent policy statements that were developed for health…”
    Get more information
    Journal Article
  10. 10

    Genetic variability of milk fatty acids by Arnould, V. M. -R., Soyeurt, H.

    Published in Journal of applied genetics (01-01-2009)
    “…The milk fatty acid (FA) profile is far from the optimal fat composition in regards to human health. The natural sources of variation, such as feeding or…”
    Get full text
    Journal Article Web Resource
  11. 11

    Comparison of two cytotoxicity assays--tetrazolium derivative reduction (MTT) and tritiated thymidine uptake--on three malignant mouse cell lines using chemotherapeutic agents and investigational drugs by Arnould, R, Dubois, J, Abikhalil, F, Libert, A, Ghanem, G, Atassi, G, Hanocq, M, Lejeune, F J

    Published in Anticancer research (01-01-1990)
    “…Two different techniques [reduction of a tetrazolium derivative (MTT) and 3HTdR uptake assays] were compared in order to evaluate the cytotoxic effects of…”
    Get more information
    Journal Article
  12. 12

    Labelled polycyanoacrylate nanoparticles for human in vivo use by Ghanem, G E, Joubran, C, Arnould, R, Lejeune, F, Fruhling, J

    Published in Applied radiation and isotopes (01-09-1993)
    “…Isobutyl and isohexyl cyanoacrylate nanoparticles are used as drug carriers, particularly for some anti-cancer drugs. Body distribution as well as…”
    Get more information
    Journal Article
  13. 13

    Utilization control in HMOs by Debrock, L, Arnould, R J

    “…Health Maintenance Organizations (HMOs) have emerged as a major vehicle to reduce transaction costs associated with defining the limits of health insurance…”
    Get more information
    Journal Article
  14. 14

    Human melanoma targeting with alpha-MSH-melphalan conjugate by Ghanem, G E, Libert, A, Arnould, R, Vercammen, A, Lejeune, F

    Published in Melanoma research (01-06-1991)
    “…A conjugate made of alpha-MSH as a drug carrier and melphalan has been designed in order to target human melanoma cells. Iodination of the alpha-MSH moiety led…”
    Get more information
    Journal Article
  15. 15

    The problem of attaining an efficient capital stock by Arnould, R J

    “…Serious problems exist with the nature of health care financing in the United States. This article summarizes problems caused by the high cost of serving an…”
    Get more information
    Journal Article
  16. 16

    Studies on factors influencing human plasma alpha-MSH by Ghanem, G, Verstegen, J, De Rijcke, S, Hanson, P, Van Onderbergen, A, Libert, A, Del Marmol, V, Arnould, R, Vercammen-Grandjean, A, Lejeune, F

    Published in Anticancer research (01-11-1989)
    “…The various physiological effects of alpha-MSH, mainly on the CNS and on pigmentation in animal models, are well documented in the literature. Only a few…”
    Get more information
    Journal Article
  17. 17

    In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivatives by Dubois, J, Arnould, R, Abikhalil, F, Hanocq, M, Atassi, G, Ghanem, G, Libert, A, Lejeune, F J

    Published in Anticancer research (01-05-1990)
    “…The cytotoxicity of hexamethylmelamine (HMM) and its metabolites was investigated in three murine cell lines: one in vitro naturally sensitive to HMM (RC) and…”
    Get more information
    Journal Article
  18. 18

    Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitro by Arnould, R, Dubois, J, Abikhalil, F, Libert, A, Ghanem, G, Atassi, G, Hanocq, M, Lejeune, F J

    Published in Anticancer research (01-05-1990)
    “…In order to assess the potential interest of replacing the murine cell lines by human cell lines for in vitro cytotoxic assays, the sensitivity and the…”
    Get more information
    Journal Article
  19. 19

    The health care cost "problem" by Arnould, R J, Finifter, D H, Schifrin, L G

    “…This serves as an introduction to this special issue devoted to a selection of papers chosen and revised from a conference on public policy entitled "Health…”
    Get more information
    Journal Article
  20. 20

    Pharmacokinetics of daunorubicin and daunorubicinol in plasma, P388 and B16 tumours. Comparison with in vitro cytotoxicity data by DUBOIS, J, HANOCQ, M, ATASSI, G, ARNOULD, R, ABIDHALIL, F

    “…The comparison of pharmacokinetics of DNR in mouse plasma, in the DNR naturally resistant B16 melanoma and in the DNR naturally sensitive P388 leukemia showed…”
    Get full text
    Journal Article